STRONG BONES

About STRONG BONES

Participants in the STRONG BONES study are 30 years of age and older and planning to undergo a sleeve gastrectomy. Patients will be randomized to receive either the study drug, Risedronate, or a placebo for six months. Changes in bone density with post-surgical weight loss will be measured and compared.

You may qualify to participate if you are:

• Planning to have a sleeve gastrectomy
• 30 years of age or older at the time of surgery

Complete this brief survey to see if you may qualify to participate!

To learn more about the study, please call 336.758.4078 or email strongbones@wfu.edu.

---

Strategies to Reduce the Onset of Sleeve Gastrectomy Associated Bone Loss (STRONG BONES)

• Awarding Agency: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
• Funding Source: National Institutes of Health (NIH)
• Principal Investigator(s): Kristen M. Beavers, PhD; Jamy D. Ard, MD
• Co-investigators: Adolfo Fernandez, MD; Daniel Beavers, PhD; Ashley Weaver, PhD; Philip Kramer, PhD, Caitlin Collins, PhD